Malarone (atovaquone / proguanil) is a CDC-recommended medication to help prevent and treat malaria. This combination medication is taken by mouth once per day. It doesn't have many side effects and can be used in children and adults.
Prevention and treatment of malaria caused by Plasmodium falciparum species
Malarone (atovaquone / proguanil) is a combination of two medications that work together to stop malaria from growing in your body.
Atovaquone works by stopping the malaria parasite from being able to make energy for itself. Without energy, the malaria parasite dies off.
Proguanil is thought to work by boosting atovaquone's effect on the malaria parasite.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Incidence not known
Blistering, peeling, loosening of skin
chills
convulsions
difficulty swallowing
fast heartbeat
hives or welts
increased sensitivity of skin to sunlight
itching, redness or other discoloration of skin
joint or muscle pain
large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs
loss of bladder control
muscle spasm or jerking of all extremities
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
rash
red, irritated eyes
red skin lesions, often with a purple center
seeing, hearing, or feeling things that are not there
severe mental changes
severe sunburn
shortness of breath
skin rash
sores, ulcers or white spots in mouth or on lips
sudden loss of consciousness
tightness in chest
unusual tiredness or weakness
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Abdominal pain
back pain
dreams
headache
itching skin
lack of or loss of strength
sores in mouth
vomiting
Less common
Acid or sour stomach
belching
blurred or loss of vision
disturbed color perception
dizziness
double vision
flu like symptoms
halos around lights
indigestion
loss of appetite
night blindness
overbright appearance of lights
stomach discomfort, upset or pain
trouble sleeping
tunnel vision
unable to sleep
Rare
Discouragement
fear
feeling sad or empty
irritability
lack of appetite
loss of interest or pleasure
nervousness
trouble concentrating
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Works well for preventing and treating malaria
Can use for traveling to areas known to have resistance to chloroquine, another antimalarial medication
Good choice for shorter trips because you only have to take it for 1 more week after leaving from the malaria area, rather than for 4 more weeks with other malaria medications (e.g., mefloquine, chloroquine)
Has relatively few side effects
Not the best choice for people with severe kidney or liver problems
Not recommended for pregnant or breastfeeding females
Taken once per day (compared to other antimalarial medications that are taken once per week)
Review your travel itinerary and see if you need to take preventative medication for malaria, like Malarone (atovaquone / proguanil), before traveling.
Malarone (atovaquone / proguanil) is available in two strengths: an adult tablet (containing 250 mg of atovaquone and 100 mg of proguanil) and a children's tablet (containing 62.5 mg of atovaquone and 25 mg of proguanil). An adult or child can be prescribed either tablet strength depending on the dose. Make sure you know which strength you have and how many tablets you need to take.
Take Malarone (atovaquone / proguanil) with food or a milk-based drink around the same time every day. If you vomit within 1 hour of taking the medication, you should take another dose. If vomiting or diarrhea continues to be a problem while taking Malarone (atovaquone / proguanil), contact your provider. You might need nausea medication or get switched to another antimalarial medication.
If you have trouble swallowing the Malarone (atovaquone / proguanil) tablets, you can crush the tablets and mix with condensed milk before taking it.
Malarone (atovaquone / proguanil) might cause vivid dreams. If the dreams bother you, let your healthcare provider know.
You should still practice other preventative measures while taking Malarone (atovaquone / proguanil) to lower your risk for malaria as much as possible. Some measures include wearing long-sleeved clothing and using bug spray.
Take Malarone (atovaquone / proguanil) exactly as prescribed to you and finish your entire course. Stopping the medication earlier than prescribed raises your chances of getting infected if you're taking it for prevention. If you're taking the medication to treat a malaria infection, stopping it too early might make your infection come back and be harder to treat.
Get medical attention if you notice any unusual fever or illness after returning from your trip abroad. While medications, like Malarone (atovaquone / proguanil), work well to prevent malaria, there's still a chance that you might get infected.
Malarone (atovaquone / proguanil) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Depending on the specific type of malaria parasite you're infected with, Malarone (atovaquone / proguanil) might not work as well to treat your malaria. This can cause your malaria infection to worsen or come back. Talk to your provider if your malaria symptoms (e.g., fever, chills, headache, etc.) come back after finishing your Malarone (atovaquone / proguanil) treatment course.
Risk factors: History of liver problems
Malarone (atovaquone / proguanil) can cause or worsen liver problems that can sometimes lead to liver failure. Your provider might order blood tests to check your liver health before and after treatment, depending on what medical conditions you have. Get medical attention right away if you notice symptoms of liver problems, such as swelling of your stomach; stomach pain; yellowing of your skin or the whites of your eyes; stool changes (black, tarry, or bloody stools); nausea; vomiting; or dark or brown urine. You might need to stop taking Malarone (atovaquone / proguanil) to prevent further liver damage.
Malarone (atovaquone / proguanil) is available in two strengths.
Adult tablet contains 250 mg of atovaquone and 100 mg of proguanil
Children's tablet contains 62.5 mg of atovaquone and 25 mg of proguanil
For malaria prevention: Typically, you'll start Malarone (atovaquone / proguanil) 1 to 2 days before you enter an area with malaria, and then continue taking the medication throughout your stay. After you leave from this area, you'll need to take Malarone (atovaquone / proguanil) for 7 more days.
Adults: The typical dose is 1 adult tablet by mouth once per day.
Children: Your child's provider will determine the right dose based on your child's body weight.
24 lbs to 45 lbs: The typical dose is 1 children's tablet by mouth once per day.
46 lbs to 67 lbs: The typical dose is 2 children's tablets by mouth once per day.
68 lbs to 88 lbs: The typical dose is 3 children's tablets by mouth once per day.
More than 88 lbs: The typical dose is 1 adult tablet by mouth once per day.
For malaria treatment:
Adults: The typical dose is 4 adult tablets by mouth once per day for 3 days.
Children: Your child's provider will determine the right dose based on your child's body weight.
11 lbs to 19 lbs: The typical dose is 2 children's tablets by mouth once per day for 3 days.
20 lbs to 23 lbs: The typical dose is 3 children's tablets by mouth once per day for 3 days.
24 lbs to 45 lbs: The typical dose is 1 adult tablet by mouth once per day for 3 days.
46 lbs to 67 lbs: The typical dose is 2 adult tablets by mouth once per day for 3 days.
68 lbs to 88 lbs: The typical dose is 3 adult tablets by mouth once per day for 3 days.
More than 88 lbs: The typical dose is 4 adult tablets by mouth once per day for 3 days.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Severe allergy to atovaquone or proguanil
Prevention of malaria in people with severe kidney problems
Prevention and treatment of malaria caused by Plasmodium falciparum species
Treatment of uncomplicated malaria
Prevention of malaria in areas of the world where there's no Malarone (atovaquone / proguanil) resistance
Extraintestinal amebiasis (a type of parasitic infection)
Treatment of malaria caused by Plasmodium falciparum in people 2 months of age or older who weigh at least 5 kg (11 pounds)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
BluePoint Laboratories. (2022). Atovaquone and proguanil hydrochloride- atovaquone and proguanil hydrochloride tablet, film coated [package insert]. DailyMed.
Centers for Disease Control and Prevention. (2023). Pregnant travelers.
Centers for Disease Control and Prevention. (2024). Appendix A: Malaria in the United States: Treatment tables.
Centers for Disease Control and Prevention. (2024). Choosing a drug to prevent malaria.
Centers for Disease Control and Prevention. (2024). Drug resistance in the malaria-endemic world.
Centers for Disease Control and Prevention. (2024). How malaria spreads.
Centers for Disease Control and Prevention. (2024). Malaria information and prophylaxis, by country [A].
Centers for Disease Control and Prevention. (2024). Malaria risk assessment for travelers.
Centers for Disease Control and Prevention. (2024). Pneumocystis pneumonia basics.
Centers for Disease Control and Prevention. (2024). Preventing malaria while traveling.
Centers for Disease Control and Prevention. (2024). Where malaria occurs.
National Heart, Lung, and Blood Institute. (2022). What is anemia?
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Liver disease.
Nixon, G. L., et al. (2013). Antimalarial pharmacology and therapeutics of atovaquone. The Journal of Antimicrobial Chemotherapy.
Srivastava, I. K., et al. (1999). A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrobial Agents and Chemotherapy.
World Health Organization. (2023). Malaria.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.